Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients After Hematopoietic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02017457
What this trial is testing

Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation.

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Carlos Graux, MD, PhD 50
Large-scale testing (Phase 3)Ended earlyNCT00324324
What this trial is testing

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
OHSU Knight Cancer Institute 240
Testing effectiveness (Phase 2)UnknownNCT01501708
What this trial is testing

Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection

Who this might be right for
LeukemiaTransplantation, Hematopoietic Stem Cell
Shanghai Jiao Tong University School of Medicine 55
Testing effectiveness (Phase 2)Study completedNCT01323920
What this trial is testing

Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndrome
Dana-Farber Cancer Institute 35
Early research (Phase 1)Study completedNCT02431208
What this trial is testing

Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Hoffmann-La Roche 85
Testing effectiveness (Phase 2)UnknownNCT04378647
What this trial is testing

BREntuximab Vedotin in SEcond LIne Therapy BEfore Transplant

Who this might be right for
Hodgkin Lymphoma, Adult
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT02861417
What this trial is testing

Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmHigh Risk Acute Myeloid LeukemiaHigh Risk Myelodysplastic Syndrome+11 more
M.D. Anderson Cancer Center 204
Testing effectiveness (Phase 2)Study completedNCT01009840
What this trial is testing

IV Busulfan Plus Bortezomib Conditioning Regimen for Second Autologous Stem Cell Transplant in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Early research (Phase 1)WithdrawnNCT04655391
What this trial is testing

Glasdegib-Based Treatment Combinations for the Treatment of Patients With Relapsed Acute Myeloid Leukemia Who Have Undergone Hematopoietic Cell Transplantation

Who this might be right for
Recurrent Acute Myeloid Leukemia
City of Hope Medical Center
Large-scale testing (Phase 3)Study completedNCT00004188
What this trial is testing

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Oncology Group 495
Not applicableActive Not RecruitingNCT03168815
What this trial is testing

Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy

Who this might be right for
ImmunocompromisedHematologic MalignancyPost Hematopoietic Stem Cell Transplant+2 more
Mount Sinai Hospital, Canada 98
Testing effectiveness (Phase 2)Study completedNCT00003116
What this trial is testing

High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Case Comprehensive Cancer Center 66
Testing effectiveness (Phase 2)Study completedNCT00148148
What this trial is testing

Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation

Who this might be right for
Hematopoietic Stem Cell TransplantationFungus Diseases
University Hospital Muenster 75
Testing effectiveness (Phase 2)Study completedNCT03389035
What this trial is testing

Transposon-manipulated Allogeneic CARCIK-CD19 Cells in Pediatric and Adult Patients With r/r ALL Post HSCT

Who this might be right for
Acute Lymphoblastic Leukemia, in Relapse
Fondazione Matilde Tettamanti Menotti De Marchi Onlus 21
Testing effectiveness (Phase 2)Study completedNCT01789255
What this trial is testing

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+115 more
National Cancer Institute (NCI) 12
Large-scale testing (Phase 3)Study completedNCT00422890
What this trial is testing

Treatment of Imminent Haematological Relapse in Patients With AML and MDS Following Allogeneic Stem Cell Transplantation With 5-azacitidine (Vidaza®)

Who this might be right for
Myeloid LeukemiaMyelodysplastic Syndrome
Technische Universität Dresden 10
Testing effectiveness (Phase 2)Study completedNCT01010217
What this trial is testing

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

Who this might be right for
Blood Stem Cell Transplant FailureLeukemiaHematologic Malignancies
M.D. Anderson Cancer Center 176
Early research (Phase 1)Looking for participantsNCT03279094
What this trial is testing

Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
City of Hope Medical Center 11
Testing effectiveness (Phase 2)Study completedNCT00003954
What this trial is testing

Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Fred Hutchinson Cancer Center 40
Early research (Phase 1)Ended earlyNCT04203017
What this trial is testing

Fecal Microbiota Transplantation After Autologous HSCT in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
St. Petersburg State Pavlov Medical University 20
Next Page